NCCN Offers Free Webinars for Patients with Non-Small Cell Lung Cancer
On August 16, 2014, NCCN will host the second of two free patient information webinars designed to allow patients and their caregivers the opportunity to listen to live expert discussions about non-small cell lung cancer.
FORT WASHINGTON, PA — On Thursday, July 24, 2014, the National Comprehensive Cancer Network ® ( NCCN ®), with the support of the NCCN Foundation ®, hosted its first of two free patient information webinars titled, “ Know What Your Doctors Know: Non-Small Cell Lung Cancer Treatment .” Registration is still open for the second NCCN patient information webinar, which is scheduled for Saturday, August 16, 2014, at 1 PM ET .
More than 100 individuals attended the July 24th webinar, featuring Gregory A. Otterson, MD, and Tracy A. Ruegg, MS, CNP, AOCN, of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute , which was designed to allow patients and their caregivers the opportunity to listen to live expert discussions about non-small cell lung cancer, as well as ask questions.
“The NCCN Foundation is excited to offer its first series of educational webinars for the patient and caregiver audience,” said Marcie Reeder, MPH, Executive Director, NCCN Foundation. “According to the American Lung Association, lung cancer is the most common cancer worldwide, and NCCN is proud to provide valuable resources, such as the NCCN patient information webinars, in order to empower patients to make informed decisions about their cancer treatment.”
The NCCN patient information webinars are based on the step-by-step treatment algorithms outlined in the NCCN Guidelines for Patients®: Non-Small Cell Lung Cancer (NSCLC) and will help patients and their caregivers understand how to find and discuss the latest treatment options with their care team, as well as how to make informed treatment decisions. The program agenda includes an introduction to NCCN, an overview of NSCLC, a review of the NCCN Guidelines for Patients®: NSCLC, and a live question and answer session with Dr. Otterson and Ms. Ruegg.
The NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ®) are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature sequential decision algorithms that address appropriate management options from initial work-up through treatment and surveillance. The NCCN Guidelines for Patients ® translate the professional guidelines into a clear, step-by-step format that people can use as a basis for discussing treatment options with their physicians and for making decisions. NCCN Guidelines for Patients do not replace the expertise and clinical judgment of the physician.
Registration is still open for the August 16th webinar, and attendees can opt-in to receive a print version of the NCCN Guidelines for Patients®: NSCLC. To learn more or register for the free event, visit NCCN.org/patientwebinars .
Reference: American Lung Association. Lung Cancer Fact Sheet . Last accessed July 11, 2014.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center at The Nebraska Medical Center, Omaha, NE; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Katie Kiley Brown, NCCN